Sign in

CIK 0001863127

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tyra Biosciences, Inc.

Sign in to watch
Ticker
TYRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831476348
Phone
+1 619-728-4760
Business address
2656 STATE STREET, CARLSBAD, CA, 92008
Open-market buys, last 90 days
$20,000
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$20,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Verjee Rehan +$20K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2023-03-21 Harris Todd Chief Executive Officer Sale −12,393 $16.00 $198K 1,701,276
2023-03-21 Harris Todd Chief Executive Officer Option exercise · Stock Option (Right to Buy) −12,393 416,619
2023-03-21 Bensen Daniel Chief Operating Officer Option exercise +14,100 $0.61 $9K 542,081
2023-03-21 Bensen Daniel Chief Operating Officer Sale −14,100 $16.00 $226K 527,981
2023-03-21 Bensen Daniel Chief Operating Officer Option exercise · Stock Option (Right to Buy) −14,100 256,029
2023-03-15 Harris Todd Chief Executive Officer Grant or award +1,808 $6.58 $12K 1,701,276
2023-03-15 Tada Hiroomi Chief Medical Officer Grant or award +1,893 $6.58 $12K 83,130
2023-02-21 Patel Piyush R. Chief Development Officer Gift −8,442 73,794
2023-02-10 MVA Investors, LLC 10% owner Sale −65,568 $13.40 $879K 22,527
2023-02-09 MVA Investors, LLC 10% owner Sale −200,000 $13.10 $2.6M 88,095
2023-01-01 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +32,800 32,800
2023-01-01 Fuhrman Alan Chief Financial Officer Grant or award · Stock Option (Right to Buy) +328,000 328,000
2022-10-12 Patel Piyush R. Chief Development Officer Gift −56,276 82,236
2022-09-15 van den Boom Esther Chief Financial Officer Grant or award +1,452 $7.66 $11K 121,897
2022-09-15 Tada Hiroomi Chief Medical Officer Grant or award +612 $7.66 $5K 81,237
2022-09-15 Patel Piyush R. Chief Development Officer Grant or award +1,040 $7.66 $8K 138,512
2022-09-15 Hudkins Robert L. Chief Technology Officer Grant or award +1,040 $7.66 $8K 273,576
2022-09-06 van den Boom Esther Chief Financial Officer Grant or award · Stock Option (Right to Buy) +105,000 105,000
2022-09-06 van den Boom Esther Chief Financial Officer Grant or award · Stock Option (Right to Buy) +89,054 89,054
2022-09-06 Tada Hiroomi Chief Medical Officer Grant or award · Stock Option (Right to Buy) +110,000 110,000

Page 16 of 21 · 417 trades